pyrazines has been researched along with Diffuse Parenchymal Lung Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, H; Hiraoka, N; Horiguchi, M; Matsuyama, A; Omura, A; Ono, S; Shiotsu, S; Suga, Y; Takumi, C; Tanaka, S; Tsuji, T; Yuba, T | 1 |
| Ihara, K; Inomata, H; Kato, J; Kikuchi, S; Koyama, R; Muramatsu, H; Nagamachi, Y; Nishisato, T; Nozawa, E; Okamoto, T; Ono, K; Tanaka, S; Yamada, H; Yamauchi, N; Yano, T | 1 |
| Ashikaga, T; Keino, D; Kinoshita, A; Kondoh, K; Morimoto, M; Ohyama, R; Yamashita, A | 1 |
| Antonini, M; Capobianchi, MR; Di Caro, A; Ippolito, G; Kobinger, GP; Lanini, S; Lauria, FN; Magrini, N; Nicastri, E; Petrosillo, N; Puro, V; Shindo, N | 1 |
| Grünberg, K; Sonneveld, P; Wittgen, BP; Wondergem, MJ; Zweegman, S | 1 |
| Chang, J; Cho, SH; Kang, W; Kim, JS; Kim, SK; Park, MS | 1 |
| Bartos, C; Berry, J; Chan, KM; Chang, AC; Kamoun, M; Mahidhara, R; Samaniego, M; Stuckey, LJ; Wadhwa, A | 1 |
| Gosney, JR; Menzies, D; Thahseen, A; Williams, R | 1 |
3 review(s) available for pyrazines and Diffuse Parenchymal Lung Disease
| Article | Year |
|---|---|
High levels of anti-SSA/Ro antibodies in COVID-19 patients with severe respiratory failure: a case-based review : High levels of anti-SSA/Ro antibodies in COVID-19.
Topics: Aged; Amides; Antibodies, Antinuclear; Antiviral Agents; Benzamidines; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Glucocorticoids; Guanidines; Humans; Hydroxychloroquine; Lung Diseases, Interstitial; Male; Methylprednisolone; Pandemics; Pneumonia, Viral; Pregnenediones; Pyrazines; Recovery of Function; Respiratory Distress Syndrome; Respiratory Insufficiency; SARS-CoV-2; Severity of Illness Index; Tomography, X-Ray Computed | 2020 |
Safety and effectiveness of low-dose lenalidomide therapy for multiple myeloma complicated with bortezomib-associated interstitial pneumonia.
Topics: Aged; Antineoplastic Agents; Boronic Acids; Bortezomib; Female; Humans; Immunologic Factors; Lenalidomide; Lung Diseases, Interstitial; Multiple Myeloma; Pyrazines; Thalidomide; Treatment Outcome | 2013 |
[Efficacy of chemotherapy combined with bortezomib for two cases of relapsed/refractory acute lymphoblastic leukemia].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Boronic Acids; Bortezomib; Cyclophosphamide; Dexamethasone; Doxorubicin; Fatal Outcome; Female; Humans; Lung Diseases, Interstitial; Octreotide; Pancreatitis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proteasome Inhibitors; Pyrazines; Recurrence; Salvage Therapy; Treatment Outcome; Vincristine | 2014 |
5 other study(ies) available for pyrazines and Diffuse Parenchymal Lung Disease
| Article | Year |
|---|---|
Ebola virus disease complicated with viral interstitial pneumonia: a case report.
Topics: Amides; Antibodies, Monoclonal; Antiviral Agents; Coinfection; Ebolavirus; Hemorrhagic Fever, Ebola; Humans; Lung Diseases, Interstitial; Malaria, Vivax; Male; Middle Aged; Plasmodium vivax; Pyrazines; Respiration, Artificial; Respiratory Insufficiency; RNA, Viral; Viral Load | 2015 |
Interstitial pneumonitis caused by Pneumocystis jirovecii pneumonia (PCP) during bortezomib treatment.
Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Humans; Lung Diseases, Interstitial; Male; Middle Aged; Multiple Myeloma; Opportunistic Infections; Pneumocystis carinii; Pneumonia, Pneumocystis; Pyrazines | 2009 |
Nonspecific interstitial pneumonitis after bortezomib and thalidomide treatment in a multiple myeloma patient.
Topics: Aged; Boronic Acids; Bortezomib; Dexamethasone; Humans; Lung Diseases, Interstitial; Male; Multiple Myeloma; Pyrazines; Thalidomide | 2010 |
Acute rejection in a highly sensitized lung transplant recipient with pre-formed donor-directed anti-HLA class II antibodies: role of bortezomib therapy.
Topics: Boronic Acids; Bortezomib; Drug Therapy, Combination; Female; Histocompatibility Antigens Class I; HLA-A Antigens; HLA-B Antigens; HLA-D Antigens; HLA-DR Antigens; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Isoantibodies; Lung Diseases, Interstitial; Lung Transplantation; Middle Aged; Protease Inhibitors; Pyrazines | 2009 |
Making light of an interstitial process.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Biopsy; Boronic Acids; Bortezomib; Cyclophosphamide; Dexamethasone; Drug Therapy, Combination; Female; Humans; Lung Diseases, Interstitial; Microscopy, Polarization; Middle Aged; Pyrazines; Radiography, Thoracic; Respiratory Sounds; Tomography, X-Ray Computed | 2012 |